NI201000080ANI201000080ANI201000080ANI201000080ANI 201000080 ANI201000080 ANI 201000080ANI 201000080 ANI201000080 ANI 201000080ANI 201000080 ANI201000080 ANI 201000080ANI 201000080 ANI201000080 ANI 201000080A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/GB2008/000454external-prioritypatent/WO2008099145A1/en
Application filed by Astrazeneca AbfiledCriticalAstrazeneca Ab
Publication of NI201000080ApublicationCriticalpatent/NI201000080A/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Abstract
El ácido 4-[4-(2-adamantilcarbamoil)-5-tert-butilpirazol-1-il]benzoico y sales farmacéuticamente aceptables de este y una forma cristalina particular del Agente (Forma 1); también se describen su uso en la inhibición de la 11BHSD1, procesos para fabricarlos y composiciones farmacéuticas que los comprenden.4- [4- (2-adamantylcarbamoyl) -5-tert-butylpyrazol-1-yl] benzoic acid and pharmaceutically acceptable salts thereof and a particular crystalline form of the Agent (Form 1); Their use in the inhibition of 11BHSD1, processes for making them and pharmaceutical compositions comprising them are also described.
Compound 4- [5 (2-amino-ethanesulfonyl) -isoquinolin-7-yl] -phenolo a pharmaceutically acceptable salt or a hydrate or salt thereof; pharmaceutical composition comprising said compound, lyophilized pharmaceutical composition; and use of the compound as antineiplasic and / or antiviral.
PHARMACEUTICAL FORMULATIONS OF IMMEDIATE RELEASE AND WITH A HIGH DRUG LOAD OF (4-CHLOROPHENYL) [4- (4-PIRIDILMETIL) FTALAZIN-1-ILO] MICRONIZED AND ITS SALTS
PHARMACEUTICAL FORMULATIONS OF IMMEDIATE RELEASE AND WITH A HIGH DRUG LOAD OF (4-CHLOROPHENYL) [4- (4-PIRIDILMETIL) FTALAZIN-1-ILO] NOT MICRONIZED, AND ITS SALTS